Simon-Kucher. Policy Requirements for a Sustainable Biosimilar Market (September 2016)

skp-cover

picto-reportpicto-videopicto-pr

Understanding the Science of Extrapolation and Defining Interchangeability – Dr. Elena Wolff-Holz, EULAR Symposium London

IMS – The Impact of Biosimilar Competition (2016)

Christian Siebert (European Commission) speech at the Biosimilar Medicines conference 2016

https://youtube.com/watch?v=INzZyNYPScw+

Biosimilar Medicines Handbook (new edition)

IMS Institute – Biosimilar Report

EAHP satellite on Biosimilar medicines

Maarten Van Baelen – Intro + Niklas Ekman – Biosimilars from the perspective of an EU regulator


pdf_file1
Maarten Van Baelen

pdf_file1
Niklas Ekman

Arnold Vulto – Biosimilars concerns of prescribers and how to address them as a hospital pharmacist

pdf_file1
Arnold Vulto

Paul Cornes – Biosimilars – can we do without them

pdf_file1
Paul Cornes

Please find  the report of the satellite symposium held at the EAHP conference here.

EGA-EBG Summary Position Regarding the WHO Biologic Qualifier Proposal (INN Working Doc. 14.342)

Sans-titre-4

Factsheet: What is a Biosimilar Medicine

6. Biosimilar Medicines_OnBM-1

Factsheet: About the Biosimilar Medicines Group

5. Biosimilar Medicines_AboutBM-1